Literature DB >> 8666525

Hepatitis B virus core particles as epitope carriers.

P Pumpens1, G P Borisova, R A Crowther, E Grens.   

Abstract

HBV core (HBc) particle is one of the most intensively studied particulate carriers for the insertion of foreign peptide sequences. Recombinant HBc protein expressed from the cloned gene undergoes the correct folding in a large variety of bacterial, yeast, insect and mammalian cells. Unique assembly properties and shape of 30/34-nm HBc particles allow substantial insertions into their primary structure without loss of their capsid-forming ability. N- and C-terminal regions, as well as the immunodominant loop in the middle of the molecule are widely accepted as targets for the introduction of foreign epitopes, ensuring retention and even enhancement of the original immunological activity of inserted sequences. Special sets of display vectors have been constructed on the basis of the cloned HBc gene. Epitope sequences of viral (BLV, FeLV, FMDV, HBV, HCV, HIV-1, HRV2, MCMV, PV-1, SIV) and nonviral (human chorionic gonadotropin) origin have been studied as model display moieties.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8666525     DOI: 10.1159/000150415

Source DB:  PubMed          Journal:  Intervirology        ISSN: 0300-5526            Impact factor:   1.763


  25 in total

1.  Combinatorial approach to hepadnavirus-like particle vaccine design.

Authors:  Jean-Noel Billaud; Darrell Peterson; Margaret Barr; Antony Chen; Matti Sallberg; Fermin Garduno; Phillip Goldstein; Wendy McDowell; Janice Hughes; Joyce Jones; David Milich
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

Review 2.  Virus-like particles production in green plants.

Authors:  Luca Santi; Zhong Huang; Hugh Mason
Journal:  Methods       Date:  2006-09       Impact factor: 3.608

3.  Construction of prokaryotic expression system of TGF-beta1 epitope gene and identification of recombinant fusion protein immunity.

Authors:  Yong-Hong Guo; Zhi-Ming Hao; Jin-Yan Luo; Jun-Hong Wang
Journal:  World J Gastroenterol       Date:  2005-10-28       Impact factor: 5.742

4.  Advantages to the use of rodent hepadnavirus core proteins as vaccine platforms.

Authors:  Jean-Noel Billaud; Darrell Peterson; Byung O Lee; Toshiyuki Maruyama; Antony Chen; Matti Sallberg; Fermin Garduño; Phillip Goldstein; Janice Hughes; Joyce Jones; David Milich
Journal:  Vaccine       Date:  2006-11-17       Impact factor: 3.641

5.  Comparison of serum humoral responses induced by oral immunization with the hepatitis B virus core antigen and the cholera toxin B subunit.

Authors:  Katleen Broos; Michiel E Janssens; Ine De Goeyse; Peter Vanlandschoot; Geert Leroux-Roels; Dirk Geysen; Yves Guisez
Journal:  Clin Vaccine Immunol       Date:  2008-03-26

6.  T cell-independent type I antibody response against B cell epitopes expressed repetitively on recombinant virus particles.

Authors:  T Fehr; D Skrastina; P Pumpens; R M Zinkernagel
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-04       Impact factor: 11.205

Review 7.  The Structural Biology of Hepatitis B Virus: Form and Function.

Authors:  Balasubramanian Venkatakrishnan; Adam Zlotnick
Journal:  Annu Rev Virol       Date:  2016-08-01       Impact factor: 10.431

8.  Cryo-EM study of Hepatitis B virus core antigen capsids decorated with antibodies from a human patient.

Authors:  Eaazhisai Kandiah; Norman R Watts; Naiqian Cheng; Giovanni Cardone; Stephen J Stahl; Theo Heller; T Jake Liang; Paul T Wingfield; Alasdair C Steven
Journal:  J Struct Biol       Date:  2011-10-25       Impact factor: 2.867

9.  Localization of the N terminus of hepatitis B virus capsid protein by peptide-based difference mapping from cryoelectron microscopy.

Authors:  J F Conway; N Cheng; A Zlotnick; S J Stahl; P T Wingfield; A C Steven
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-08       Impact factor: 11.205

10.  Generation of fusion protein EGFRvIII-HBcAg and its anti-tumor effect in vivo.

Authors:  Xiao-yi Duan; Dong-gang Han; Ming-xin Zhang; Jian-sheng Wang
Journal:  J Exp Clin Cancer Res       Date:  2009-09-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.